PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.41%
Revenue growth at 50-75% of META's 23.22%. Martin Whitman would worry about competitiveness or product relevance.
9.76%
Gross profit growth under 50% of META's 24.84%. Michael Burry would be concerned about a severe competitive disadvantage.
-4.89%
Negative EBIT growth while META is at 35.27%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.89%
Negative operating income growth while META is at 35.27%. Joel Greenblatt would press for urgent turnaround measures.
-2.65%
Negative net income growth while META stands at 33.97%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3.03%
Negative EPS growth while META is at 34.83%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1.54%
Negative diluted EPS growth while META is at 35.23%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.08%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.42%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-1.69%
Negative OCF growth while META is at 2.51%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-25.50%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
522.21%
10Y revenue/share CAGR under 50% of META's 1172.67%. Michael Burry would suspect a lasting competitive disadvantage.
124.41%
5Y revenue/share CAGR under 50% of META's 476.62%. Michael Burry would suspect a significant competitive gap or product weakness.
82.11%
3Y revenue/share CAGR under 50% of META's 187.48%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
452.66%
10Y OCF/share CAGR under 50% of META's 1182.18%. Michael Burry would worry about a persistent underperformance in cash creation.
138.81%
Below 50% of META's 450.09%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
100.21%
3Y OCF/share CAGR at 50-75% of META's 169.84%. Martin Whitman would suspect weaker recent execution or product competitiveness.
2013.08%
Similar net income/share CAGR to META's 1839.28%. Walter Schloss would see parallel tailwinds or expansions for both firms.
155.29%
Below 50% of META's 1066.32%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
79.75%
Below 50% of META's 339.65%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
468.09%
Below 50% of META's 1361.37%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
95.96%
Below 50% of META's 379.24%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
45.98%
3Y equity/share CAGR at 50-75% of META's 88.88%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.30%
AR growth well above META's 25.24%. Michael Burry fears inflated revenue or higher default risk in the near future.
-8.66%
Inventory is declining while META stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.08%
Similar asset growth to META's 5.28%. Walter Schloss finds parallel expansions or investment rates.
4.67%
75-90% of META's 5.69%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
0.65%
Debt shrinking faster vs. META's 614.29%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
15.33%
R&D growth drastically higher vs. META's 7.45%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
20.35%
SG&A growth well above META's 19.92%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.